Trader Note — 9333 total
Helmerich & Payne heads into its August 6 earnings date with the stock down 15% over the past month, target prices slipping, and a short-interest position that refuses to fully unwind. The Street's direction of travel…
HEICO enters the week of July 8 with a quiet but telling divergence: the stock is up 8% over the past month while analysts keep nudging targets higher — yet short sellers have added modestly to positions and options…
Welltower heads into its July 27 earnings print with fresh analyst upgrades, a stock up nearly 15% in a month, and a borrow market so loose it barely registers as a short story. The headline development this week is…
The Hartford Insurance Group enters its July 23 earnings window with the stock up 5.4% on the week, options traders leaning bullish, and the borrow market offering zero friction for anyone wanting to push back. The…
L3Harris Technologies enters its July 23 earnings report as the relative laggard in a defense sector that has had a strong week — and the gap between where the stock trades and where the Street thinks it should be…
Halliburton heads into its July 20 Q2 earnings print with a stock down 14% over the past month, a cluster of insider sales at higher prices, and an analyst community that remains broadly constructive but has quietly…
Goldman Sachs heads into its July 14 Q2 earnings report having reclaimed $1,043 — up 3.1% on the week — with analysts rushing to lift targets and options traders the most call-skewed they have been in a year. The most…
Global Payments has climbed 17% over the past month yet attracted significantly more short interest — a tension that sets up an interesting dynamic heading into Q2 results on August 6. The short side has been…
Gilead Sciences heads into the back half of summer with a notable catalyst in the rearview mirror — a bellwether upgrade that broke a run of analyst caution and helped push the stock to its best weekly gain in…
General Mills has rallied nearly 7% since last Tuesday — yet the bears who held firm through an ugly earnings day have barely flinched. The core tension is simple. The stock printed a strong post-earnings recovery,…
General Dynamics heads into its July 29 earnings print with the stock up nearly 6% on the week and analysts quietly turning more constructive — a setup that puts the burden on management to validate rising…
Arthur J. Gallagher & Co. is the standout story in insurance brokerage this week — a 11% move higher in five sessions, a flood of analyst target upgrades, and shorts caught leaning the wrong way. The analyst response…
FuelCell Energy has spent the past week unwinding sharply from the melt-up that defined late June, with the stock dropping 28% to $25.96 — yet shorts are still adding rather than banking profits, keeping the bull-bear…
FISV enters earnings season with a notable split between Wall Street's growing caution and a cluster of insider buying that looks like conviction at the bottom. The most striking development this week came directly…
Fifth Third Bancorp enters its July 17 Q2 earnings report with a notable split: short sellers have been retreating over the past week even as the broader month saw them rebuild positions, leaving the stock up 11% over…
Fastenal enters its July 14 Q2 earnings report with an unusual split: options traders are the most bullish they've been in months, while the analyst community remains firmly on the fence — and the stock just posted its…
ExxonMobil enters the final stretch before its July 31 Q2 earnings print with a notable reversal in short positioning — the most significant change since last week's note documented bears retreating. Short interest has…
Equifax enters its July 15 earnings report with a clean 10% weekly gain behind it, a shrinking short base, and a Street consensus that remains broadly constructive — yet options traders have quietly shifted toward…
Edgewell Personal Care heads into its August earnings window with a notable split: the Street is turning more constructive just as short sellers maintain a meaningful position — and the stock has already rallied 34%…
Edwards Lifesciences enters its July 23 earnings date with the Street more constructive than it has been all year — and the stock's 10% monthly rally giving bulls something to point to. The analyst picture is unusually…
